Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

209.16 +3.34 (+1.62%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iqvia Holdings Inc

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
A Look Into IQVIA Hldgs Inc's Price Over Earnings
Via Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission
From IQVIA
Via Business Wire
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
From IQVIA
Via Business Wire
Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
Analyst Expectations for IQVIA Hldgs's Future
Via Benzinga
How Is The Market Feeling About IQVIA Hldgs?
Via Benzinga
IQVIA Builds on its Strategic Collaboration with argenx to Provide Safety Systems and Services
From IQVIA
Via Business Wire
IQVIA Appoints Richard Staub III President of Research & Development Solutions
From IQVIA
Via Business Wire
IQVIA Named a Leader in Pharmacovigilance Solutions in IDC MarketScape Report
From IQVIA
Via Business Wire
How Is The Market Feeling About IQVIA Hldgs?
Via Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
Earnings Outlook For IQVIA Hldgs
Via Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
From IQVIA Holdings Inc.
Via Business Wire
What 7 Analyst Ratings Have To Say About IQVIA Hldgs
Via Benzinga
Here's How Much $1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much $1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
Via Benzinga
IQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual Global Healthcare Conference on September 12, 2023
From IQVIA
Via Business Wire
3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of
Worries about biotech stocks are way overdone, so the sector should make a big comeback in the coming months. 
Via InvestorPlace
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
IQVIA Q2: 5.3% Sales Growth, Additional Share Repurchase, Reduced FY23 Guidance & More
IQVIA Holdings, Inc. (NYSE: IQV) posted Q2 sales of $3.728 billion, up 5.3% Y/Y on a reported basis and 5.5% at constant currency (CC),  
Via Benzinga
IQVIA Reports Second-Quarter 2023 Results
From IQVIA Holdings Inc.
Via Business Wire
Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes IQVIA Holdings Inc. (NYSE: IQV) 
Via Benzinga
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
From IQVIA Holdings Inc.
Via Business Wire
IQVIA and the NBA Selected for Abbott’s UNIVANTS of Healthcare Excellence Award
From IQVIA
Via Business Wire
IQVIA selected ‘Leader’ in Everest Group Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
IQVIA Wins Prestigious “Best AI-based Solution for Healthcare” Award in 2023 Artificial Intelligence Breakthrough Awards
From IQVIA
Via Business Wire
IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach for Global Label Management
From IQVIA
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.